Newsroom

Industry News

25 May

Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) has Demonstrated Promising Efficacy and Safety in Ongoing Phase 1/2 Clinical Trial NEW YORK and CLEVELAND, May 25, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare...

Read more

25 May

Miami Marlins Debut CLR Roasters Home Game Commercial

MIAMI, FL–(Marketwired – May 25, 2017) – CLR Roasters‘ Café La Rica espresso, “The official Cafecito of the Miami Marlins”, formally debuted its home game commercial video on the main ballpark jumbotron of the 37,442-seat Marlins Park during the 7th Inning Stretch on May 10. The video was launched...

Read more

25 May

Aemetis Enters into Multi-Year Biodiesel Supply Agreement with BP

CUPERTINO, CA / ACCESSWIRE / May 25, 2017 / Aemetis, Inc. (AMTX) announced today that its Universal Biofuels subsidiary in India has signed a three-year biofuels supply agreement with BP Singapore Pte Limited (BPS), the regional trading arm of BP Plc, which has an expanding biofuels portfolio. “The agreement...

Read more

25 May

BioLineRx Reports First Quarter 2017 Financial Results

TEL AVIV, Israel, May 25, 2017 /PRNewswire/ — BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today reports its financial results for the first quarter ended March 31, 2017. Highlights and achievements during the first quarter 2017 and to date: Continued advancing the Company’s lead...

Read more

24 May

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

– Orphan designation provides increased communication and guidance from regulators and 10-year market exclusivity upon marketing authorization – Actinium’s two leading drug candidates, Iomab-B and Actimab-A, now have orphan designation in both the U.S. and EU NEW YORK, May 24, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium”...

Read more

24 May

Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study

PLYMOUTH MEETING, Pa., May 24, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that its HIV vaccine, PENNVAX®-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated in a human study by an HIV vaccine. The vaccine candidate, PENNVAX-GP, consists of...

Read more

19 May

Abeona Therapeutics to Present at Multiple Upcoming Conferences

NEW YORK and CLEVELAND, May 19, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced that members of the management team will present at the following upcoming conferences: Event: Cell & Gene Exchange Panelist:...

Read more

17 May

Actinium Pharmaceuticals Announces Appointment of Hematology Expert Dr. Richard Stone of the Dana-Farber Cancer Institute to its Scientific Advisory Board

NEW YORK, May 17, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that Dr. Richard Stone, Chief of Staff and Program Director, Acute Leukemia at the Dana-Farber Cancer...

Read more

Page 1 of 23412345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address